Rural United States Experience of Incorporation of a Technologically Advanced and Procedurally Complex Cardiovascular Program - the Sanford Trans-Catheter Aortic Valve Replacement Experience

Trans-catheter aortic valve replacement (TAVR) was approved by the U.S. Food and Drug Administration in 2012 for treatment of severe symptomatic aortic stenosis in non-surgical and high risk patients. Implementation of this complex procedure requires a comprehensive heart team approach. Rural demogr...

Full description

Saved in:

Bibliographic Details
Published in:	South Dakota medicine Vol. 69; no. 8; p. 351
Main Authors:	Stys, Tomasz, Stys, Adam, Raizada, Amol, Nykamp, Verlyn, Maziarz, David, Santos, Angelo, Laurich, Chad, Jonsson, Orvar, Dodin, Jamal, Petraskova, Terezia, Molga, Maria
Format:	Journal Article
Language:	English
Published:	United States 01-08-2016
Subjects:	Aged, 80 and over Aortic Valve Stenosis - surgery Female Humans Male Patient Care Team Program Evaluation Rural Population South Dakota Transcatheter Aortic Valve Replacement Treatment Outcome
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Trans-catheter aortic valve replacement (TAVR) was approved by the U.S. Food and Drug Administration in 2012 for treatment of severe symptomatic aortic stenosis in non-surgical and high risk patients. Implementation of this complex procedure requires a comprehensive heart team approach. Rural demographics in the Midwest pose many challenges related to low volumes of operations both at institutional and individual levels, leading to serious concerns about the quality of care delivered in such a setting. We compared the TAVR data at the University of South Dakota Sanford Medical Center to the national registry with the aim of looking at differences in outcomes of this procedure in a rural setting.
ISSN:	0038-3317